Reaction
Primary Amyloidosis reporting signals
As of the last recalculation, Primary Amyloidosis appears in 250 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is BORTEZOMIB (PRR 259.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bortezomib | 132 | 259.2 | 259.6 |
| Daratumumab | 46 | 117.3 | 117.4 |
| Bendamustine Hcl | 14 | 79.6 | 79.6 |
| Cyclophosphamide Injection, Solution | 92 | 67.9 | 67.9 |
| Cyclophosphamide | 92 | 67.9 | 67.9 |
| Cyclophosphamide For Injection | 92 | 67.9 | 67.9 |
| Ixazomib | 9 | 27.0 | 27.0 |